ketoconazole has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 3 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the clinical efficacy of ketoconazole (KCZ) as an inhibitory enzyme on ovarian steroidogenesis, in prevention of ovarian hyper- stimulation syndrome (OHSS) during assisted reproductive technology (ART) in patients with polycystic ovarian syndrome (PCOS)." | 9.11 | The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles. ( Ahmadi, J; Amirchaghmaghi, E; Baghestani, AR; Owj, M; Tehrani-Nejad, ES, 2005) |
| "To evaluate the role of ketoconazole in prevention of ovarian hyperstimulation syndrome (OHSS) in women with the polycystic ovary syndrome (PCOS) undergoing ovarian stimulation with gonadotropins." | 9.10 | A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. ( Alborzi, S; Pakniat, M; Parsanezhad, ME; Schmidt, EH, 2003) |
| "To investigate the clinical efficacy of mild inhibition of ovarian steroidogenesis by very low-dose ketoconazole during induction of ovulation in patients with polycystic ovary syndrome (PCOS)." | 9.09 | Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome. ( Barr, I; Diamant, YZ; Eldar-Geva, T; Gal, M; Margalioth, EJ; Orly, J, 1999) |
| "To assess the clinical efficacy of ketoconazole (KCZ) as an inhibitory enzyme on ovarian steroidogenesis, in prevention of ovarian hyper- stimulation syndrome (OHSS) during assisted reproductive technology (ART) in patients with polycystic ovarian syndrome (PCOS)." | 5.11 | The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles. ( Ahmadi, J; Amirchaghmaghi, E; Baghestani, AR; Owj, M; Tehrani-Nejad, ES, 2005) |
| "To evaluate the role of ketoconazole in prevention of ovarian hyperstimulation syndrome (OHSS) in women with the polycystic ovary syndrome (PCOS) undergoing ovarian stimulation with gonadotropins." | 5.10 | A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome. ( Alborzi, S; Pakniat, M; Parsanezhad, ME; Schmidt, EH, 2003) |
| "To investigate the clinical efficacy of mild inhibition of ovarian steroidogenesis by very low-dose ketoconazole during induction of ovulation in patients with polycystic ovary syndrome (PCOS)." | 5.09 | Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome. ( Barr, I; Diamant, YZ; Eldar-Geva, T; Gal, M; Margalioth, EJ; Orly, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parsanezhad, ME | 1 |
| Alborzi, S | 1 |
| Pakniat, M | 1 |
| Schmidt, EH | 1 |
| Owj, M | 1 |
| Tehrani-Nejad, ES | 1 |
| Amirchaghmaghi, E | 1 |
| Baghestani, AR | 1 |
| Ahmadi, J | 1 |
| Gal, M | 1 |
| Eldar-Geva, T | 1 |
| Margalioth, EJ | 1 |
| Barr, I | 1 |
| Orly, J | 1 |
| Diamant, YZ | 1 |
3 trials available for ketoconazole and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
| Article | Year |
|---|---|
A double-blind, randomized, placebo-controlled study to assess the efficacy of ketoconazole for reducing the risk of ovarian hyperstimulation syndrome.
Topics: Adult; Androgen Antagonists; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combin | 2003 |
The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fertilization in Vitr | 2005 |
Attenuation of ovarian response by low-dose ketoconazole during superovulation in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Estradiol; Female; Humans; | 1999 |